Market Wrap – July 9
On July 9, 2025, Indian markets faced global headwinds as US tariff hikes targeted pharma and metals, but strong domestic developments in steel, infra, and upcoming IPOs like Anthem Biosciences kept investor sentiment balanced.
On July 9, 2025, Indian markets faced global headwinds as US tariff hikes targeted pharma and metals, but strong domestic developments in steel, infra, and upcoming IPOs like Anthem Biosciences kept investor sentiment balanced.
From improving PMI numbers and tariff shifts to retail growth and a buzzing IPO pipeline, India’s economic momentum continues to gain pace despite global uncertainties. Sectors like textiles, retail, pharma, and power are showing strength, while investor focus remains strong on Q1 earnings and global cues.
On July 2, 2025, Indian markets experienced cautious trading amid global political uncertainty and upcoming trade deadlines. Tesla’s dip impacted sentiment, while domestic action was driven by new listings like HDB Financial, robust auto sales from Hyundai and Maruti, and significant corporate announcements from Adani, Lupin, JSW Energy, and others. Profit booking was seen in midcaps and PSUs, while pharma, auto, and metals attracted strong buying.
July 1, 2025, marked a dynamic start to H2 for Indian markets. Strong GST collections, a solid manufacturing PMI, and auto sector growth provided positive cues. Global tech stocks rallied after Canada scrapped its digital tax, while Indian indices remained stable amid mixed sectoral performance. Key corporate actions and energy price changes also shaped investor sentiment.
25 June 2025 saw global relief as crude fell post-ceasefire, boosting market sentiment. Strong corporate updates, IPO buzz, and domestic policy changes drove sectoral moves, with midcaps and pharma gaining. Eyes remain on Fed signals and upcoming listings.
This change offers traders dual expiry opportunities, enabling smarter strategies and potential arbitrage between NSE and BSE within the same week.
While global headwinds like the Iran-Israel conflict and rising crude prices are creating near-term volatility, India’s strong domestic flows and resilient macro indicators like positive WPI and robust DII buying are providing stability. Sector rotation into midcaps, realty, and oil & gas reflects investor optimism. However, continued vigilance is needed, especially around global supply disruptions and USFDA observations in the pharma sector.
MTNL stock surged 18% after the government revealed ₹2,134.61 crore earnings from asset monetisation. Learn how MTNL’s strategy is boosting its financial health and investor confidence.